| Characteristic | Complete vaccination against COVID-19 | Overall N = 6041 | p-value2 | |
| No N = 5491 | Yes N = 551 | |||
| Clinical severity at admission |
|
|
| <0.001 |
| Asymptomatic/Mild | 103 (18.8) | 24 (43.6) | 127 (21.0) |
|
| Moderate | 142 (25.9) | 14 (25.5) | 156 (25.8) |
|
| Severe | 231 (42.1) | 17 (30.9) | 248 (41.1) |
|
| Critical | 73 (13.2) | 0 (0.0) | 73 (12.1) |
|
| At least one complication |
|
|
| 0.654 |
| No | 490 (89.3) | 48 (87.3) | 538 (89.1) |
|
| Yes | 59 (10.7) | 7 (12.7) | 66 (10.9) |
|
| Pulmonary embolism |
|
|
| 0.702 |
| No | 531 (96.7) | 53 (96.4) | 586 (96.7) |
|
| Yes | 18 (3.3) | 2 (3.6) | 20 (3.3) |
|
| Respiratory complication |
|
|
| 0.711 |
| No | 528 (96.2) | 54 (98.2) | 584 (96.4) |
|
| Yes | 21 (3.8) | 1 (1.8) | 22 (3.6) |
|
| Renal complication |
|
|
| 0.441 |
| No | 530 (96.6) | 52 (94.5) | 584 (96.4) |
|
| Yes | 19 (3.4) | 3 (5.5) | 22 (3.6) |
|
| Cardiovascular complication |
|
|
| 0.127 |
| No | 544 (99.1) | 53 (96.4) | 599 (98.8) |
|
| Yes | 5 (0.9) | 2 (3.6) | 7 (1.2) |
|
| Neurological complication |
|
|
| 0.384 |
| No | 533 (97.1) | 55 (100.0) | 590 (97.4) |
|
| Yes | 16 (2.9) | 0 (0.0) | 16 (2.6) |
|
| ICU admission |
|
|
| <0.001 |
| No | 203 (37.0) | 34 (61.8) | 237 (39.2) |
|
| Yes | 346 (63.0) | 21 (38.2) | 367 (60.8) |
|
| Evolution |
|
|
| <0.001 |
| Dead | 167 (30.4) | 5 (9.1) | 172 (28.5) |
|
| Alive | 382 (69.6) | 50 (90.9) | 432 (71.5) |
|
| Hospitalization duration (days), median (IQR) | 10 (6 - 15) | 10 (8 - 14) | 10 (6 - 15) | 0.741 |